These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 3834952

  • 1. Lymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients.
    Kastelan M, Rudolf M, Hrsak M, Stojkovic R, Gamulin S.
    Biomed Pharmacother; 1985; 39(8):442-4. PubMed ID: 3834952
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A, Pascual MR, Pérez R, Lage A.
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [Abstract] [Full Text] [Related]

  • 3. Hormone receptors and Japanese breast cancer.
    Matsumoto K, Kitamura Y, Sugano H.
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [Abstract] [Full Text] [Related]

  • 4. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y, Tashiro H, Hisamatsu K, Shinozuka K.
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [Abstract] [Full Text] [Related]

  • 5. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM.
    Cancer Res; 1987 Apr 01; 47(7):1830-5. PubMed ID: 3545455
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phylloid breast tumors and three steroid hormone receptors.
    Lang BA, Vermousek I, Simicková M, Cernoch M, Nekulová M, Paćovský Z, Rejthar A.
    Neoplasma; 1997 Apr 01; 44(1):53-7. PubMed ID: 9201281
    [Abstract] [Full Text] [Related]

  • 9. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
    Ben-David M, Wittliff JL, Fekete M, Kadar T, Biran S, Schally AV.
    Biomed Pharmacother; 1988 Apr 01; 42(5):327-34. PubMed ID: 3191209
    [Abstract] [Full Text] [Related]

  • 10. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
    Baron M, Keystone EC, Gladman DD, Lee P, Poplonski L.
    Clin Exp Immunol; 1981 Oct 01; 46(1):70-6. PubMed ID: 6978216
    [Abstract] [Full Text] [Related]

  • 11. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurküla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B, International Breast Cancer Study Group.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1571-81. PubMed ID: 17077359
    [Abstract] [Full Text] [Related]

  • 12. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
    Murphy LC, Hilsenbeck SG, Dotzlaw H, Fuqua SA.
    Clin Cancer Res; 1995 Feb 01; 1(2):155-9. PubMed ID: 9815968
    [Abstract] [Full Text] [Related]

  • 13. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S, Mangia A, D'Amico C, Simone G.
    Pathologica; 2003 Feb 01; 95(1):31-6. PubMed ID: 12735283
    [Abstract] [Full Text] [Related]

  • 14. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
    Zhang QX, Borg A, Fuqua SA.
    Cancer Res; 1993 Dec 15; 53(24):5882-4. PubMed ID: 8261397
    [Abstract] [Full Text] [Related]

  • 15. Effects of insulin on phytohemagglutinin-P, concanavalin-A, and pokeweed mitogen in diabetic and nondiabetic lymphocytes.
    Glassman AB, Lindsay JH, Bennett CE, Hodges ER.
    Ann Clin Lab Sci; 1981 Dec 15; 11(1):9-14. PubMed ID: 7011167
    [Abstract] [Full Text] [Related]

  • 16. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO.
    J Clin Oncol; 2007 Oct 20; 25(30):4772-8. PubMed ID: 17876012
    [Abstract] [Full Text] [Related]

  • 17. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 20; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 18. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
    Fernandez MD, Alaghband-Zadeh J, Burn JI.
    Clin Oncol; 1983 Sep 20; 9(3):245-50. PubMed ID: 6616999
    [Abstract] [Full Text] [Related]

  • 19. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC, Crommelin MA, Repelaer van Driel OJ, Tutein Nolthenius-Puylaert MC, Vreugdenhil G, Coebergh JW.
    Ned Tijdschr Geneeskd; 1998 Aug 01; 142(31):1772-8. PubMed ID: 9856143
    [Abstract] [Full Text] [Related]

  • 20. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M.
    Cytometry B Clin Cytom; 2005 Mar 01; 64(1):43-52. PubMed ID: 15668953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.